Perioperative Virtual Reality Intervention for Pain and Anxiety During Vasectomies
A Perioperative Virtual Reality Intervention for Pain and Anxiety Management During Vasectomies: A Randomized Controlled Trial
1 other identifier
interventional
90
1 country
1
Brief Summary
The goal of this clinical trial is to learn if a virtual reality (VR) program (TRIPP) can reduce pain, anxiety, and distress in adult men (aged 18+) undergoing a vasectomy under local anesthesia. The main questions it aims to answer are:
- Does using VR during a vasectomy lower patients' pain during the procedure compared to standard care?
- Does VR reduce anxiety and distress compared to standard care?
- Are patients more satisfied with their experience when using VR compared to standard care? Researchers will compare two groups:
- VR group: Patients will use a VR headset with a guided meditation program (TRIPP) during their vasectomy.
- Control group: Patients will receive standard care (no VR). Participants will:
- Be randomly assigned to either the VR group or control group.
- Complete brief questionnaires before, during, and after the procedure (about 15-20 minutes each time).
- (VR group only) Use a VR headset during the procedure and provide optional feedback about the experience. Why is this important? Vasectomies are typically done with local anesthesia (pain relief), but many patients still feel anxiety or discomfort. VR may help distract and relax patients, improving their experience. This study will help health professionals understand if VR could be a useful option for future patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2025
CompletedStudy Start
First participant enrolled
July 2, 2025
CompletedFirst Posted
Study publicly available on registry
July 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
May 5, 2026
July 1, 2025
1.1 years
June 13, 2025
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Numeric Rating Scale (NRS) for Pain Severity
During and immediately following the procedure, patients will be momentarily interrupted to give a brief NRS verbal response question measure of their level of acute pain, this is on a scale of 0-10; 10 = most severe pain.
Perioperatively (midway through procedure) and immediately following the procedure.
Secondary Outcomes (8)
Numeric Rating Scale (NRS) for Discomfort Severity
Perioperatively (midway through procedure) and immediately following the procedure.
Numeric Rating Scale (NRS) for Anxiety Severity
Perioperatively (midway through procedure) and immediately following the procedure.
PROMIS Pain Intensity Scale Total Score
Within 10 minutes postoperatively (in the recovery room)
State Trait Anxiety Inventory Total Score
10 minutes preoperatively (baseline) and within 10 minutes postoperatively (in the recovery room.
National Comprehensive Cancer Network (NCCN) Anxiety Thermometer Score (adapted from Distress Thermometer)
10 minutes preoperatively (baseline) and within 10 minutes postoperatively (in the recovery room.
- +3 more secondary outcomes
Study Arms (2)
Standard Vasectomy
ACTIVE COMPARATORVasectomy treatment as usual, with local anesthetic, without virtual reality.
Virtual Reality Vasectomy
EXPERIMENTALThis group of participants will receive undergo their vasectomy with the virtual reality intervention alongside the local anesthetic.
Interventions
Participants will engage in the TRIPP relaxation app on the MetaQuest 3 VR headset.
Eligibility Criteria
You may qualify if:
- years of age or older.
- Can speak and read English.
- Have elected for a vasectomy.
- Are scheduled to undergo their vasectomy under local anesthesia at the Men's Health Clinic
You may not qualify if:
- Those who are not competent to provide informed consent (e.g., due to cognitive impairment).
- Those who are unable to participate in a VR intervention (e.g., due to visual or auditory impairment).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Manitoba Men's Health Clinic
Winnipeg, Manitoba, R3P 2S8, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Renée El-Gabalawy, MA, PhD, C. Psych
University of Manitoba
- PRINCIPAL INVESTIGATOR
Premal Patel, MD, FRCSC
Manitoba Men's Health Clinic
- PRINCIPAL INVESTIGATOR
Ahmed M Zalam, B.Sc.
University of Manitoba
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 13, 2025
First Posted
July 8, 2025
Study Start
July 2, 2025
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
May 5, 2026
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
Study data and information from the study will not be sent outside of the University of Manitoba. Records containing health related information will be treated as confidential in accordance with Personal Health Information Act of Manitoba (PHIA). Information gathered in this research study may be published or presented in public forums, however names and other identifying personal information will not be revealed. Data will be coded and names will not be released.